Keyword Connections

sitagliptin

Journals

3

1 Analytical chemistry

2 biofactors (oxford, england)

3 Frontiers in oncology

Research Groups

0

No Research Group Connected

Bibliographies

13

1 Sitagliptin protects liver against aflatoxin B1-induced hepatotoxicity through upregulating Nrf2/ARE/HO-1 pathway.

2 Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer.

3 efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin on atherosclerosis, β-cell function, and glycemic control in japanese patients with type 2 diabetes mellitus who are treatment naïve or poorly responsive to antidiabetes agents: a multicenter, prospective observational, uncontrolled study

4 the persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: studies with hk-2 cells in vitro and normal rats in vivo

5 Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats.

6 Sitagliptin prevents isoproterenol-induced myocardial infarction in rats by modulating nitric oxide synthase enzymes.

7 Sitagliptin and Simvastatin Interaction Causing Rhabdomyolysis and AKI

8 Efficacy and hypoglycemic risk of sitagliptin in obese/overweight patients with type 2 diabetes compared with GLP-1 receptor agonists: A meta-analysis.

9 A ProspectIve, OpeN-Label, Randomized Study Comparing EffIcacy and Safety of Teneligliptin VErsus Sitagliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: INSITES Study.

10 sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus

11 microflora disturbance during progression of glucose intolerance and effect of sitagliptin: an animal study

12 sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals

13 Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).